Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K. The Sucampo logo and the tagline, The Science of Innovation, are registered trademarks of Sucampo AG. AMITIZA is a registered trademark of Sucampo AG.
View Top Employees from Sucampo Pharmaceuticals, Inc.Website | http://www.sucampo.com |
Ticker | SCMP |
Revenue | $230.1 million |
Funding | $293.1 million |
Employees | 39 (32 on RocketReach) |
Founded | 1996 |
Address | 805 King Farm Boulevard Suite 550, Rockville, Maryland 20850, US |
Phone | (301) 961-3400 |
Fax | (301) 961-3440 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Biotechnology, Pharmaceuticals, Healthcare, Drug Manufacturing & Research |
Competitors | Evoke Pharma, Ironwood Pharmaceuticals, Ritter Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular Sucampo Pharmaceuticals, Inc. employee's phone or email?
The Sucampo Pharmaceuticals, Inc. annual revenue was $230.1 million in 2024.
Yijun Sun is the Senior .Director, Biostatistics and Clinical Data Management of Sucampo Pharmaceuticals, Inc..
32 people are employed at Sucampo Pharmaceuticals, Inc..
Sucampo Pharmaceuticals, Inc. is based in Rockville, Maryland.
The NAICS codes for Sucampo Pharmaceuticals, Inc. are [325, 32541, 3254, 32, 541, 5417, 54].
The SIC codes for Sucampo Pharmaceuticals, Inc. are [283, 28].